Watson H. David's Insider Trades & SAST Disclosures
Watson H. David's most recent trade in Argan, Inc. was a trade of 11,745 Common Stock done . Disclosure was reported to the exchange on Dec. 23, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Watson H. David.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2024 | 11,745 | 68,636 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2024 | 10,000 | 12,000 | - | - | Performance-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 7,500 | 25,500 | - | - | Earnings Per Share Performance-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2024 | 4,000 | 18,001 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 4,000 | 22,001 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2024 | 3,334 | 14,667 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2024 | 3,333 | 18,001 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 3,000 | 22,000 | - | - | Performance-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2024 | 2,286 | 54,933 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 2,000 | 13,334 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2024 | 1,958 | 56,891 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2024 | 1,856 | 52,647 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 139.89 per share. | 23 Dec 2024 | 500 | 0 (0%) | 0% | 139.9 | 69,945 | Common Stock |
| Argan, Inc. | Watson H. David | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2024 | 40,000 | 11,334 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | Watson David H. | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.25 per share. | 18 Dec 2024 | 12,502 | 61,291 (0%) | 0% | 64.3 | 803,254 | Common Stock |
| Argan, Inc. | H. Watson David | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 146.05 per share. | 18 Dec 2024 | 10,000 | 51,291 (0%) | 0% | 146.1 | 1,460,500 | Common Stock |
| Argan, Inc. | David Watson H. | Director, PRESIDENT AND CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Dec 2024 | 500 | 50,791 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 10,000 | 58,000 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 6,666 | 51,334 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.60 per share. | 10 Sep 2024 | 2,241 | 46,589 (0%) | 0% | 54.6 | 122,359 | Common Stock |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.78 per share. | 10 Sep 2024 | 2,200 | 48,789 (0%) | 0% | 36.8 | 80,916 | Common Stock |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 77.79 per share. | 24 Jul 2024 | 15,134 | 44,348 (0%) | 0% | 77.8 | 1,177,274 | Common Stock |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2024 | 32,000 | 100,000 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2024 | 32,000 | 68,000 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.60 per share. | 13 Jun 2024 | 9,012 | 53,360 (0%) | 0% | 37.6 | 338,851 | Common Stock |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.30 per share. | 13 Jun 2024 | 6,122 | 59,482 (0%) | 0% | 50.3 | 307,937 | Common Stock |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 30,000 | 132,000 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2024 | 10,000 | 28,667 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Apr 2024 | 10,000 | 19,000 | - | - | Performance-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2024 | 8,000 | 18,000 | - | - | Earnings Per Share Performance-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.68 per share. | 16 Apr 2024 | 5,367 | 42,419 (0%) | 0% | 41.7 | 223,697 | Common Stock |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2024 | 4,000 | 29,000 | - | - | Performance-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Apr 2024 | 4,000 | 24,667 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 3,334 | 18,667 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 3,333 | 21,334 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2024 | 3,000 | 162,000 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 2,253 | 37,052 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 1,975 | 34,799 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 1,929 | 44,348 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2023 | 32,000 | 159,000 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.81 per share. | 09 Oct 2023 | 5,000 | 32,824 (0%) | 0% | 33.8 | 169,050 | Common Stock |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2023 | 12,000 | 25,334 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2023 | 10,000 | 10,000 | - | - | Earnings Per Share Performance-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2023 | 5,000 | 25,000 | - | - | Performance-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2023 | 5,000 | 191,000 | - | - | Stock Option to Purchase Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2023 | 3,505 | 24,400 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2023 | 3,505 | 13,334 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2023 | 3,424 | 27,824 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | David H. Watson | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2023 | 3,424 | 22,001 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | SVP AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2022 | 10,000 | 16,667 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | SVP AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2022 | 10,000 | 30,000 | - | - | Performance-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | SVP AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2022 | 10,000 | 186,000 | - | - | Stock Option to Purchase Common Stock | |
| Argan, Inc. | David H. Watson | SVP AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2022 | 3,411 | 20,895 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | David H. Watson | SVP AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2022 | 8,984 | 17,484 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | David H. Watson | SVP AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2022 | 8,000 | 20,000 | - | - | Performance-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | SVP & CFO | Sale of securities on an exchange or to another person at price $ 52.69 per share. | 16 Apr 2021 | 12,248 | 8,500 (0%) | 0% | 52.7 | 645,347 | Common Stock |
| Argan, Inc. | David H. Watson | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2021 | 10,000 | 10,000 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2021 | 10,000 | 28,000 | - | - | Performance-Based Restricted Stock Units | |
| Argan, Inc. | David H. Watson | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2021 | 10,000 | 176,000 | - | - | Stock Option to purchase Common Stock | |
| Argan, Inc. | David H. Watson | SVP & CFO | Sale of securities on an exchange or to another person at price $ 54.18 per share. | 16 Apr 2021 | 939 | 20,748 (0%) | 0% | 54.2 | 50,875 | Common Stock |
| Argan, Inc. | David H. Watson | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2021 | 17,987 | 21,687 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | David H. Watson | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2021 | 8,000 | 18,000 | - | - | Performance-Based Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges